IN-VITRO ACTIVITIES OF AZITHROMYCIN, CLARITHROMYCIN, ERYTHROMYCIN, AND TETRACYCLINE AGAINST 13 STRAINS OF CHLAMYDIA-PNEUMONIAE

Citation
L. Welsh et al., IN-VITRO ACTIVITIES OF AZITHROMYCIN, CLARITHROMYCIN, ERYTHROMYCIN, AND TETRACYCLINE AGAINST 13 STRAINS OF CHLAMYDIA-PNEUMONIAE, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 212-214
Citations number
16
Categorie Soggetti
Pharmacology & Pharmacy",Microbiology
ISSN journal
00664804
Volume
40
Issue
1
Year of publication
1996
Pages
212 - 214
Database
ISI
SICI code
0066-4804(1996)40:1<212:IAOACE>2.0.ZU;2-8
Abstract
Thirteen strains of Chlamydia pneumoniae were evaluated for their in v itro susceptibilities to azithromycin, clarithromycin, erythromycin, a nd tetracycline. The MIC ranges were 0.125 to 0.5 mu g/ml for azithrom ycin, 0.031 to 1.0 mu g/ml for clarithromycin, 0.125 to 1.0 mu g/ml fo r erythromycin, and 0.125 to 1.0 mu g/ml for tetracycline, The ranges for the minimal lethal concentrations were 0.125 to 0.5 mu g/ml for az ithromycin. 0.031 to 1.0 mu g/ml for clarithromycin, 0.125 to 1.0 mu g /ml for erythromycin, and 0.25 to 1.0 mu g/ml for tetracycline. Clarit hromycin and azithromycin were the most active antibiotics against C. pneumoniae in vitro.